
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CircRNA_101505 sensitizes hepatocellular carcinoma cells to cisplatin by sponging miR-103 and promotes oxidored-nitro domain-containing protein 1 expression
Yanwei Luo, Yunfeng Fu, Rong Huang, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 71
Yanwei Luo, Yunfeng Fu, Rong Huang, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance
Chaochu Cui, Jianbo Yang, Li Xiao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 165
Chaochu Cui, Jianbo Yang, Li Xiao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 165
CircGPR137B/miR-4739/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma
Lianyong Liu, Mingjun Gu, Junhua Ma, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 99
Lianyong Liu, Mingjun Gu, Junhua Ma, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 99
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications
Huibin Song, Dongcheng Liu, Shaowei Dong, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 104
Huibin Song, Dongcheng Liu, Shaowei Dong, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 104
Circular RNA: Biogenesis, Degradation, Functions and Potential Roles in Mediating Resistance to Anticarcinogens
Xiuchao Geng, Youchao Jia, Yuhao Zhang, et al.
Epigenomics (2019) Vol. 12, Iss. 3, pp. 267-283
Open Access | Times Cited: 95
Xiuchao Geng, Youchao Jia, Yuhao Zhang, et al.
Epigenomics (2019) Vol. 12, Iss. 3, pp. 267-283
Open Access | Times Cited: 95
CircRNAs in anticancer drug resistance: recent advances and future potential
Tianwei Xu, Mengwei Wang, Lihua Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 92
Tianwei Xu, Mengwei Wang, Lihua Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 92
CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis
Fushuang Zheng, Ran Xu
Biomedicine & Pharmacotherapy (2020) Vol. 124, pp. 109828-109828
Open Access | Times Cited: 86
Fushuang Zheng, Ran Xu
Biomedicine & Pharmacotherapy (2020) Vol. 124, pp. 109828-109828
Open Access | Times Cited: 86
Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells
Yanwei Luo, Rong Gui
Journal of Gynecologic Oncology (2020) Vol. 31, Iss. 5
Open Access | Times Cited: 80
Yanwei Luo, Rong Gui
Journal of Gynecologic Oncology (2020) Vol. 31, Iss. 5
Open Access | Times Cited: 80
Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p
Yeqing Xu, Aizhu Qiu, Feng Peng, et al.
Neoplasma (2020) Vol. 68, Iss. 01, pp. 108-118
Open Access | Times Cited: 77
Yeqing Xu, Aizhu Qiu, Feng Peng, et al.
Neoplasma (2020) Vol. 68, Iss. 01, pp. 108-118
Open Access | Times Cited: 77
Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway
Yun Zhou, Weiwei Tang, Han Zhuo, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 4786-4797
Open Access | Times Cited: 61
Yun Zhou, Weiwei Tang, Han Zhuo, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 4786-4797
Open Access | Times Cited: 61
circCCNY enhances lenvatinib sensitivity and suppresses immune evasion in hepatocellular carcinoma by serving as a scaffold for SMURF1 mediated HSP60 degradation
Lei Yang, Wenliang Tan, Min Wang, et al.
Cancer Letters (2025) Vol. 612, pp. 217470-217470
Closed Access | Times Cited: 1
Lei Yang, Wenliang Tan, Min Wang, et al.
Cancer Letters (2025) Vol. 612, pp. 217470-217470
Closed Access | Times Cited: 1
Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR‐605/FOXO3/ABCB1 axis
Jin Li, Xiaoping Qin, Ruishan Wu, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 9, pp. 5152-5161
Open Access | Times Cited: 52
Jin Li, Xiaoping Qin, Ruishan Wu, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 9, pp. 5152-5161
Open Access | Times Cited: 52
Circ-NOLC1 promotes epithelial ovarian cancer tumorigenesis and progression by binding ESRP1 and modulating CDK1 and RhoA expression
Shuo Chen, Wu Wu, Qian-hui Li, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 41
Shuo Chen, Wu Wu, Qian-hui Li, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 41
The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma
Sha Qin, Yitao Mao, Chen Xue, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 12, pp. 3059-3079
Open Access | Times Cited: 41
Sha Qin, Yitao Mao, Chen Xue, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 12, pp. 3059-3079
Open Access | Times Cited: 41
N6-methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through acting as RNA sponges
Congjie Xu, Jiaquan Zhou, Xiaoting Zhang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 8
Congjie Xu, Jiaquan Zhou, Xiaoting Zhang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 8
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis
Yu Tian, Meng Zhang, Lixia Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Yu Tian, Meng Zhang, Lixia Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Cisplatin Resistance in Cancer Therapy: Causes and Overcoming Strategies
S Shruthi, K. Bhasker Shenoy
ChemistrySelect (2024) Vol. 9, Iss. 25
Closed Access | Times Cited: 7
S Shruthi, K. Bhasker Shenoy
ChemistrySelect (2024) Vol. 9, Iss. 25
Closed Access | Times Cited: 7
Role of Epigenetics for the Efficacy of Cisplatin
Tatjana Lumpp, Sandra Stößer, Franziska Fischer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1130-1130
Open Access | Times Cited: 6
Tatjana Lumpp, Sandra Stößer, Franziska Fischer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1130-1130
Open Access | Times Cited: 6
New insights into the potential of exosomal circular RNAs in mediating cancer chemotherapy resistance and their clinical applications
Qiang Li, Yuhao Zhang, Peikan Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117027-117027
Open Access | Times Cited: 6
Qiang Li, Yuhao Zhang, Peikan Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117027-117027
Open Access | Times Cited: 6
circFN1 Mediates Sorafenib Resistance of Hepatocellular Carcinoma Cells by Sponging miR-1205 and Regulating E2F1 Expression
Cheng Yang, Zhitao Dong, Hong Han, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 22, pp. 421-433
Open Access | Times Cited: 47
Cheng Yang, Zhitao Dong, Hong Han, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 22, pp. 421-433
Open Access | Times Cited: 47
The Role of Circular RNAs in Therapy Resistance of Patients With Solid Tumors
Maria Papatsirou, Pinelopi I. Artemaki, Andreas Scorilas, et al.
Personalized Medicine (2020) Vol. 17, Iss. 6, pp. 469-490
Closed Access | Times Cited: 47
Maria Papatsirou, Pinelopi I. Artemaki, Andreas Scorilas, et al.
Personalized Medicine (2020) Vol. 17, Iss. 6, pp. 469-490
Closed Access | Times Cited: 47
<p>Circ_0006528 Contributes to Paclitaxel Resistance of Breast Cancer Cells by Regulating miR-1299/CDK8 Axis</p>
Guoqi Liu, Zhenxing Zhang, Qing Song, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 9497-9511
Open Access | Times Cited: 46
Guoqi Liu, Zhenxing Zhang, Qing Song, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 9497-9511
Open Access | Times Cited: 46
The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma
Man Wang, Fei Yu, Xinzhe Chen, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 21, pp. 13-27
Open Access | Times Cited: 42
Man Wang, Fei Yu, Xinzhe Chen, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 21, pp. 13-27
Open Access | Times Cited: 42
Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma
Yanwei Luo, Jinqi Ma, Fengxia Liu, et al.
Head & Neck (2020) Vol. 42, Iss. 12, pp. 3702-3711
Closed Access | Times Cited: 40
Yanwei Luo, Jinqi Ma, Fengxia Liu, et al.
Head & Neck (2020) Vol. 42, Iss. 12, pp. 3702-3711
Closed Access | Times Cited: 40
Splicing factor SNRPA associated with microvascular invasion promotes hepatocellular carcinoma metastasis through activating NOTCH1 /Snail pathway and is mediated by circSEC62 /miR ‐625‐5p axis
Zhaohong Mo, Ruixi Li, Chuanlin Cao, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 5, pp. 1022-1037
Closed Access | Times Cited: 14
Zhaohong Mo, Ruixi Li, Chuanlin Cao, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 5, pp. 1022-1037
Closed Access | Times Cited: 14
Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors
Qingchun Mu, Lv Y, Chunmei Luo, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 30
Qingchun Mu, Lv Y, Chunmei Luo, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 30